1. Executive Summary (Confidence: High)

HBM Healthcare Investments AG (SIX: HBMN) is a major Swiss investment firm with a market capitalization of approximately CHF 1.56 billion and net assets exceeding CHF 1. billion. Founded in 2001 by former Roche CFO Henri B. Meier, the company builds high-value portfolios across the human medicine, biotechnology, medical technology, and diagnostics sectors. HBM distinguishes itself through an "active investment approach," often taking board seats in private companies to steer them toward successful trade sales or initial public offerings (IPOs). With a globally diversified footprint spanning North America, Europe, and Asia, HBM provides its shareholders with exposure to a curated selection of over 45 high-growth healthcare companies, delivering consistent returns through dividends and capital gains.